Detalles de la búsqueda
1.
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
Headache
; 63(10): 1351-1358, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955395
2.
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
Cephalalgia
; 42(8): 769-780, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331009
3.
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.
Eur J Neurol
; 29(7): 2129-2137, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302681
4.
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
J Headache Pain
; 23(1): 112, 2022 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038833
5.
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine-preventive medications in the phase 3b FOCUS study.
Headache
; 61(9): 1376-1386, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374086
6.
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study.
J Headache Pain
; 22(1): 68, 2021 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246226
7.
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study.
J Headache Pain
; 22(1): 152, 2021 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922436
8.
Pridopidine activates neuroprotective pathways impaired in Huntington Disease.
Hum Mol Genet
; 25(18): 3975-3987, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27466197
9.
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid.
Headache
; 62(4): 530-533, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35383922
10.
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.
Oncologist
; 21(1): 7-15, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26668251
11.
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Neurol Ther
; 13(3): 655-675, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557959
12.
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.
J Pain Res
; 16: 1673-1682, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37223438
13.
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.
J Pain Res
; 16: 1311-1319, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101521
14.
Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. "Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials". Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819-828. Epublished November 2020.
Naunyn Schmiedebergs Arch Pharmacol
; 394(11): 2343-2346, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581836
15.
Evaluation of a Biologic Formulation Using Customized Design of Experiment and Novel Multidimensional Robustness Diagrams.
J Pharm Sci
; 107(3): 797-806, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29107045
16.
Immunogenicity assessment of tbo-filgrastim in cancer patients receiving chemotherapy.
Bioanalysis
; 10(15): 1221-1228, 2018 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30058363
17.
An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis.
Nat Biotechnol
; 21(3): 294-301, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12598908
18.
First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
Cancer Chemother Pharmacol
; 75(5): 929-39, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740691
19.
Efficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer receiving chemotherapy.
Clin Breast Cancer
; 14(2): 101-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24485296
20.
Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression.
Biochem Biophys Res Commun
; 294(4): 835-42, 2002 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-12061783
Resultados
1 -
20
de 20
1
Próxima >
>>